Chardan Healthcare Acquisition 2 Corp. (CHAQ.U), announced the pricing of their $85 million SPAC IPO this evening and the units are expected to begin trading, tomorrow, Friday, April 24th, under the symbol NYSE: CHAQ.U.
Chardan Healthcare 2, intends to focus on companies in the healthcare industry located in North America, and will be led by Gbola Amussa, as Executive Chairman, and Jonas Grossman, as President, CEO and Director. George Kaufman, will be CFO and Head of Strategy.
Total SPAC deal count for 2020 year-to-date is now 15 with $4.61 billion in gross proceeds raised. The offering is expected to close on Tueday, April 28, 2020.
Chardan acted as sole book-running manager for the offering. Loeb & Loeb LLP and Kirkland & Ellis LLP, were Issuer’s Counsel and Underwriter’s Counsel, respectively. Marcum LLP acted as auditor.